| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute disseminated encephalomyelitis associated with positive voltage gated potassium channel complex antibody
|
Kaliakatsos, Marios
|
|
2013
|
|
2 |
p. 147-150
4 p.
|
artikel
|
| 2 |
A pilot MRI study of white and grey matter involvement by multiple sclerosis spinal cord lesions
|
Kearney, H.
|
|
2013
|
|
2 |
p. 103-108
6 p.
|
artikel
|
| 3 |
Bifactor structure of clinical disability in relapsing multiple sclerosis
|
Chamot, Eric
|
|
2014
|
|
2 |
p. 176-185
10 p.
|
artikel
|
| 4 |
Bilateral trochlear nerve palsy in a patient with neuromyelitis optica
|
Rizek, Philippe
|
|
2014
|
|
2 |
p. 273-275
3 p.
|
artikel
|
| 5 |
Burden of multiple sclerosis on direct, indirect costs and quality of life: National US estimates
|
Campbell, Jonathan D.
|
|
2014
|
|
2 |
p. 227-236
10 p.
|
artikel
|
| 6 |
Cardiovascular autonomic dysfunction in multiple sclerosis: A meta-analysis
|
Racosta, Juan Manuel
|
|
2015
|
|
2 |
p. 104-111
8 p.
|
artikel
|
| 7 |
CCSVI-A. A call to clinicans and scientists to vocalise in an Internet age
|
Gafson, Arie R.
|
|
2014
|
|
2 |
p. 143-146
4 p.
|
artikel
|
| 8 |
Chloride channel loss of function linked with white matter disease
|
Dale, Russell C.
|
|
2014
|
|
2 |
p. 141-142
2 p.
|
artikel
|
| 9 |
Comment on “Hierarchical genetic organization of human cortical surface area” by Chen et al. [Science 335 (2012) 1634–1636 (supporting information)]
|
Ciccarelli, Olga
|
|
2013
|
|
2 |
p. 90-91
2 p.
|
artikel
|
| 10 |
Corrigendum to “Inflammatory cytokines in relapsing-remitting multiple sclerosis (RRMS) patients” [Mult. Scler. Relat. Disord. 3 (2014) 741]
|
Shajarian, M.
|
|
2015
|
|
2 |
p. 180-
1 p.
|
artikel
|
| 11 |
Crystal-storing histiocytosis: An unusual relapsing inflammatory CNS disorder
|
Costanzi, Chiara
|
|
2012
|
|
2 |
p. 95-99
5 p.
|
artikel
|
| 12 |
Does glatiramer acetate provoke hepatitis in multiple sclerosis?
|
Sinagra, Emanuele
|
|
2014
|
|
2 |
p. 266-268
3 p.
|
artikel
|
| 13 |
ECTRIMS 2012: Treatment highlights
|
Giovannoni, Gavin
|
|
2013
|
|
2 |
p. 68-72
5 p.
|
artikel
|
| 14 |
Editors’ welcome
|
Banwell, Brenda
|
|
2015
|
|
2 |
p. 93-94
2 p.
|
artikel
|
| 15 |
Editors’ Welcome
|
Banwell, Brenda
|
|
2014
|
|
2 |
p. 139-140
2 p.
|
artikel
|
| 16 |
Editors' welcome
|
Banwell, Brenda
|
|
2012
|
|
2 |
p. 55-
1 p.
|
artikel
|
| 17 |
Editors' welcome and a working definition for a multiple sclerosis cure
|
Banwell, Brenda
|
|
2013
|
|
2 |
p. 65-67
3 p.
|
artikel
|
| 18 |
Effects of rituximab on lymphocytes in multiple sclerosis and neuromyelitis optica
|
Graves, Jennifer
|
|
2014
|
|
2 |
p. 244-252
9 p.
|
artikel
|
| 19 |
Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years
|
Benson, L.A.
|
|
2014
|
|
2 |
p. 186-193
8 p.
|
artikel
|
| 20 |
Emerging disease modifying treatments—A therapeutics update from ECTRIMS/ACTRIMS, Amsterdam, 2011
|
Giovannoni, Gavin
|
|
2012
|
|
2 |
p. 56-58
3 p.
|
artikel
|
| 21 |
Epstein–Barr virus in the multiple sclerosis brain – An evasive culprit
|
Pender, Michael P.
|
|
2012
|
|
2 |
p. 61-63
3 p.
|
artikel
|
| 22 |
Fabry disease mimicking multiple sclerosis: Lessons from two case reports
|
Shribman, S.E.
|
|
2015
|
|
2 |
p. 170-175
6 p.
|
artikel
|
| 23 |
Genetic evidence for a pathogenic role for the vitamin D3 metabolizing enzyme CYP24A1 in multiple sclerosis
|
Ramasamy, Adaikalavan
|
|
2014
|
|
2 |
p. 211-219
9 p.
|
artikel
|
| 24 |
High-dose intravenous interferon-beta in multiple sclerosis patients with high-titer neutralizing antibodies (HINABS II) – A pilot study
|
Hegen, H.
|
|
2014
|
|
2 |
p. 220-226
7 p.
|
artikel
|
| 25 |
High doses of biotin in chronic progressive multiple sclerosis: A pilot study
|
Sedel, Frédéric
|
|
2015
|
|
2 |
p. 159-169
11 p.
|
artikel
|
| 26 |
Improved detection of focal cortical lesions using 7T magnetisation transfer imaging in patients with multiple sclerosis
|
Abdel-Fahim, R.
|
|
2014
|
|
2 |
p. 258-265
8 p.
|
artikel
|
| 27 |
Increased deep gray matter iron is present in clinically isolated syndromes
|
Quinn, Matthew P.
|
|
2014
|
|
2 |
p. 194-202
9 p.
|
artikel
|
| 28 |
Is 3D MPRAGE better than the combination DIR/PSIR for cortical lesion detection at 3T MRI?
|
Nelson, Flavia
|
|
2014
|
|
2 |
p. 253-257
5 p.
|
artikel
|
| 29 |
Late-onset neutropenia during long-term rituximab therapy in neuromyelitis optica
|
Plate, Annika
|
|
2014
|
|
2 |
p. 269-272
4 p.
|
artikel
|
| 30 |
Lessons from clinical trials of alemtuzumab in multiple sclerosis
|
Chaudhuri, Abhijit
|
|
2013
|
|
2 |
p. 92-95
4 p.
|
artikel
|
| 31 |
Migraine and multiple sclerosis: Epidemiology and approach to treatment
|
Gelfand, Amy A.
|
|
2013
|
|
2 |
p. 73-79
7 p.
|
artikel
|
| 32 |
Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice
|
Freedman, Mark S.
|
|
2014
|
|
2 |
p. 147-155
9 p.
|
artikel
|
| 33 |
Moyamoya: Another multiple sclerosis mimic
|
Zaheer, Fariha
|
|
2012
|
|
2 |
p. 100-103
4 p.
|
artikel
|
| 34 |
Multiple sclerosis and risk behavior
|
Hawkes, Christopher H.
|
|
2012
|
|
2 |
p. 59-60
2 p.
|
artikel
|
| 35 |
Multiple sclerosis in Colombia and other Latin American Countries
|
Toro, Jaime
|
|
2013
|
|
2 |
p. 80-89
10 p.
|
artikel
|
| 36 |
Multiple sclerosis: The role of melatonin and N-acetylserotonin
|
Anderson, George
|
|
2015
|
|
2 |
p. 112-123
12 p.
|
artikel
|
| 37 |
Natalizumab-related progressive multifocal leukoencephalopathy in Greece
|
Mitsikostas, Dimos D.
|
|
2014
|
|
2 |
p. 203-210
8 p.
|
artikel
|
| 38 |
[No title]
|
Murray, Jock
|
|
2013
|
|
2 |
p. 151-
1 p.
|
artikel
|
| 39 |
Observations on the brain vasculature in multiple sclerosis: A historical perspective
|
Rae-Grant, Alex D.
|
|
2014
|
|
2 |
p. 156-162
7 p.
|
artikel
|
| 40 |
On the origin of EDSS
|
Kurtzke, John F.
|
|
2015
|
|
2 |
p. 95-103
9 p.
|
artikel
|
| 41 |
Patient-rated ease of use and functional reliability of an electronic autoinjector for self-injection of subcutaneous interferon beta-1a for relapsing multiple sclerosis
|
Singer, B.
|
|
2012
|
|
2 |
p. 87-94
8 p.
|
artikel
|
| 42 |
Preserved in vivo response to interferon-alpha in multiple sclerosis patients with neutralising antibodies against interferon-beta (REPAIR study)
|
Magyari, Melinda
|
|
2013
|
|
2 |
p. 141-146
6 p.
|
artikel
|
| 43 |
Progression of disability in multiple sclerosis: A study of factors influencing median time to reach an EDSS value
|
Ramachandran, Sudarshan
|
|
2013
|
|
2 |
p. 109-116
8 p.
|
artikel
|
| 44 |
Pseudotumoral rebound of multiple sclerosis in a pregnant patient after stopping natalizumab
|
Verhaeghe, Alexander
|
|
2014
|
|
2 |
p. 279-281
3 p.
|
artikel
|
| 45 |
Quantification of blood-to-brain transfer rate in multiple sclerosis
|
Taheri, Saeid
|
|
2013
|
|
2 |
p. 124-132
9 p.
|
artikel
|
| 46 |
Recurrent refrains in a patient with multiple sclerosis: Earworms or musical hallucinations?
|
Husain, Farhat
|
|
2014
|
|
2 |
p. 276-278
3 p.
|
artikel
|
| 47 |
Regional gray matter atrophy in relapsing remitting multiple sclerosis: Baseline analysis of multi-center data
|
Datta, Sushmita
|
|
2015
|
|
2 |
p. 124-136
13 p.
|
artikel
|
| 48 |
Relationship between muscle strength parameters and functional capacity in persons with mild to moderate degree multiple sclerosis
|
Kjølhede, Tue
|
|
2015
|
|
2 |
p. 151-158
8 p.
|
artikel
|
| 49 |
Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosis
|
Altmann, D.R.
|
|
2014
|
|
2 |
p. 237-243
7 p.
|
artikel
|
| 50 |
Sexual dysfunction in patients with multiple sclerosis
|
Orasanu, Bogdan
|
|
2013
|
|
2 |
p. 117-123
7 p.
|
artikel
|
| 51 |
Subclinical MRI disease activity influences cognitive performance in MS patients
|
Damasceno, Alfredo
|
|
2015
|
|
2 |
p. 137-143
7 p.
|
artikel
|
| 52 |
Teaching case: A man with a progressive gait impairment and visual compromise
|
Toro, Jaime
|
|
2015
|
|
2 |
p. 176-179
4 p.
|
artikel
|
| 53 |
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis
|
Baker, David
|
|
2012
|
|
2 |
p. 64-75
12 p.
|
artikel
|
| 54 |
The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics
|
Lindsey, J.W.
|
|
2012
|
|
2 |
p. 81-86
6 p.
|
artikel
|
| 55 |
The effect of daclizumab on brain atrophy in relapsing-remitting multiple sclerosis
|
Borges, Isabela T.
|
|
2013
|
|
2 |
p. 133-140
8 p.
|
artikel
|
| 56 |
The epigenetics of multiple sclerosis and other related disorders
|
van den Elsen, Peter J.
|
|
2014
|
|
2 |
p. 163-175
13 p.
|
artikel
|
| 57 |
Unmet needs of multiple sclerosis patients in the community
|
Lonergan, Roisin
|
|
2015
|
|
2 |
p. 144-150
7 p.
|
artikel
|
| 58 |
Urine: An under-studied source of biomarkers in multiple sclerosis?
|
Dobson, Ruth
|
|
2012
|
|
2 |
p. 76-80
5 p.
|
artikel
|
| 59 |
Views on disclosing mistreatment: A focus group study of differences between people with MS and their caregivers
|
Shapiro, Johanna
|
|
2013
|
|
2 |
p. 96-102
7 p.
|
artikel
|
Tijdschrift beschrijving